What inspired this Wish List Request?
There is a growing demand among pharmaceutical, biotech, chemical, and process industry users for advanced batch process monitoring and evaluation tools in JMP. Current JMP offerings do not provide an integrated workflow for modeling batch evolution or multivariate batch-level quality prediction. This limits JMP’s ability to address use cases where process monitoring, deviation detection, and end-of-batch prediction are required, especially in regulated industries.
Please describe the new or improved feature or solution you would like to see.
JMP should introduce a dedicated batch process modeling module with advanced analytics for batch processes. This module should support Batch Evolution Modeling (BEM), enabling alignment and modeling of variable-length batch trajectories using normalized time scales such as percent completion or key process stages.
More details here
What would the value be to you and/or other users if this new feature is provided?
This feature will enable advanced, real-time batch process monitoring and predictive analytics within JMP, making it possible to quickly detect abnormal batches and support both root cause analysis and process optimization. By expanding JMP’s capabilities in regulated, high-value manufacturing sectors such as pharma, biopharma (PAT, CPV), biotech, chemicals, and food, it will reduce reliance on competing tools like SIMCA for their regulatory reporting requirements. This will strengthen JMP’s position in the market, supporting customer retention and driving further adoption among process industry users.
Is this an external customer request?
Yes, customers in the biopharmaceutical sector have specifically requested integrated multivariate batch evaluation and real-time process monitoring features in JMP. Biocon and Intas Biologics are two prominent users who actively use JMP in their MSAT applications. Providing this capability in JMP will make batch-level modeling, regulatory reporting, and Continued Process Verification much easier for these users, who continue to rely on SIMCA for this functionality.
Is there a competitive software package that has this feature or solution that we should be aware of?
Yes, SIMCA by Sartorius is widely usedfor batch process evaluation, with capabilities such as BEM, BLM, real-time MSPC, OPLS modeling, and powerful visualization/reporting. [Relevant details attached}.
Will this impact a renewal, expansion, or adoption at a customer, and does this put an account at risk if we do not address this?
Biopharma MSAT users have requested that this feature be included in JMP, as they currently use JMP and SIMCA in parallel. Despite SIMCA’s limitations compared to JMP’s extensive capabilities, SIMCA continues to be adopted for this feature due to its critical role in regulatory requirements under ICH Q8, Q9, and Q10, as well as for PAT and CPV. Users continue to invest in costlier SIMCA licenses specifically for this functionality, highlighting its importance for compliance.
Thanks, Chandra, for putting all this together. On top of that, I have also been receiving BEM capability (Multivariate PLS, OPLS) queries from Sun Pharma since 2022. BEM is definitely considered a best practice or advanced tool within a robust PAT/CPV strategy—especially for complex or multivariate processes. Compared to the costlier SIMCA licenses, this feature can be included in JMP Pro, offering an all-in-one pharma analytics solution.
Thank you for submitting this request! This will be reviewed by a product manager shortly, who will let you know if there are any updates to the status.
